Literature DB >> 12789061

'Boussignac' continuous positive airway pressure system: practical use in a prehospital medical care unit.

François Templier1, François Dolveck, Michel Baer, Marcel Chauvin, Dominique Fletcher.   

Abstract

Continuous positive airway pressure in acute cardiogenic pulmonary edema is rarely used by prehospital emergency care units, because of the particular technical drawbacks of existing equipment. The aim of this one year prospective descriptive open study without a control group was to assess the technical feasibility of using the Boussignac continuous positive airway pressure system (Vygon) in a prehospital medical care service. Statistical comparisons were performed using Student's t-test or a Wilcoxon T-test. There were 57 decisions to use continuous positive airway pressure. Seven records were excluded. Four patients were intubated on the scene and six within one hour after hospital admission. The respiratory rate and transcutaneous oxygen saturation improved significantly for all of the other patients (Student's t-test P < 0.001). The Boussignac continuous positive airway pressure system has many advantages, including flexibility and pressure monitoring, lower oxygen consumption, and ease of use. These should allow this technique to be used more widely by prehospital teams.

Entities:  

Mesh:

Year:  2003        PMID: 12789061     DOI: 10.1097/00063110-200306000-00003

Source DB:  PubMed          Journal:  Eur J Emerg Med        ISSN: 0969-9546            Impact factor:   2.799


  9 in total

1.  Novel indications for the Boussignac CPAP valve.

Authors:  Marco Cigada; Giovanluigi Elia; Michele Umbrello; Matteo Giacomini; Giovanni Mistraletti; Concezione Tommasino; Gaetano Iapichino
Journal:  Intensive Care Med       Date:  2006-12-09       Impact factor: 17.440

2.  The use of the Boussignac CPAP device during cardiogenic pulmonary edema (CPE): why add air to the oxygen gas source?

Authors:  François Templier; Maidei Gugu Kabayadondo; Frédéric Thys
Journal:  Intensive Care Med       Date:  2011-06-21       Impact factor: 17.440

3.  Influence of lung collapse distribution on the physiologic response to recruitment maneuvers during noninvasive continuous positive airway pressure.

Authors:  Gianmaria Cammarota; Rosanna Vaschetto; Emilia Turucz; Fabrizio Dellapiazza; Davide Colombo; Cristiana Blando; Francesco Della Corte; Salvatore Maurizio Maggiore; Paolo Navalesi
Journal:  Intensive Care Med       Date:  2011-05-13       Impact factor: 17.440

4.  Is helmet CPAP first line pre-hospital treatment of presumed severe acute pulmonary edema?

Authors:  Giuseppe Foti; Fabio Sangalli; Lorenzo Berra; Stefano Sironi; Marco Cazzaniga; Gian Piera Rossi; Giacomo Bellani; Antonio Pesenti
Journal:  Intensive Care Med       Date:  2008-11-22       Impact factor: 17.440

5.  An improved Boussignac device for the delivery of non-invasive CPAP: the SUPER-Boussignac.

Authors:  Giacomo Bellani; Giuseppe Foti; Ester Spagnolli; Luigi Castagna; Nicolò Patroniti; Antonio Pesenti
Journal:  Intensive Care Med       Date:  2009-01-24       Impact factor: 17.440

6.  Out-of-hospital noninvasive ventilation: epidemiology, technology and equipment.

Authors:  John Scott Baird; Thyyar M Ravindranath
Journal:  Pediatr Rep       Date:  2012-04-24

7.  Effect of noninvasive ventilation on intubation risk in prehospital patients with acute cardiogenic pulmonary edema: a retrospective study.

Authors:  Birgit Andrea Gartner; Christophe Fehlmann; Laurent Suppan; Marc Niquille; Olivier T Rutschmann; François Sarasin
Journal:  Eur J Emerg Med       Date:  2020-02       Impact factor: 4.106

8.  Practical use, effects and complications of prehospital treatment of acute cardiogenic pulmonary edema using the Boussignac CPAP system.

Authors:  Eva Eiske Spijker; Maarten de Bont; Matthijs Bax; Maro Sandel
Journal:  Int J Emerg Med       Date:  2013-04-08

9.  Boussignac continuous positive airway pressure for the management of acute cardiogenic pulmonary edema: prospective study with a retrospective control group.

Authors:  Willem Dieperink; Tiny Jaarsma; Iwan C C van der Horst; Wybe Nieuwland; Karin M Vermeulen; Hanka Rosman; Leon P H J Aarts; Felix Zijlstra; Maarten W N Nijsten
Journal:  BMC Cardiovasc Disord       Date:  2007-12-20       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.